Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process-Reference-Cited by-同舟云学术

Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process

Published:2021-12 Issue:6 Volume:51 Page:1331-1341
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Roofeh David,Barratt Shaney L.,Wells Athol U,Kawano-Dourado Leticia,Tashkin Donald,Strand Vibeke,Seibold James,Proudman Susanna,Brown Kevin K,Dellaripa Paul F,Doyle Tracy,Leonard Thomas,Matteson Eric L,Oddis Chester V,Solomon Joshua J,Sparks Jeffrey A,Vassallo Robert,Maxwell Lara,Beaton Dorcas,Christensen Robin,Townsend Whitney,Khanna Dinesh

Funder

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference98 articles.

1. Systemic sclerosis;Denton;Lancet,2017

2. Interstitial lung disease in systemic sclerosis;Wells;Press Medicale,2014

3. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

4. Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

5. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature;Wallace;Curr Opin Rheumatol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interstitial Lung Disease Associated with Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-05-07

2. Divergent perspectives: exploring the relationships between St. George’s Respiratory Questionnaire and outcome measures in systemic sclerosis–associated interstitial lung disease;Clinical Rheumatology;2024-04-04

3. Overview of Management and Outcome Assessment in Systemic Sclerosis;Scleroderma;2024

4. Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2023-05

5. Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort;Rheumatology;2022-11-15